Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9657-9669
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9657
Table 3 Univariate and multivariate analyses of factors associated with overall survival
CharacteristicUnivariate analysis
Multivariate analysis
Hazard ratio
95%CI
P value
Hazard ratio
95%CI
P value
Age, yr (≥ 65 vs < 65)1.230.88-1.710.233
Gender (Female vs Male)0.940.66-1.360.753
Ethnicity (Han vs Kazakh)1.050.75-1.460.782
Tumor size (≥ 3 cm vs < 3 cm)0.920.64-1.330.658
Tumor location (Upper vs Middle and Lower)1.080.80-1.470.605
AJCC stage (I vs II vs III vs IV)1.210.96-1.510.100
Lymph node metastasis (No vs Yes)1.410.99-2.000.058
Metastasis (No vs Yes)1.700.83-3.480.147
Degree of differentiation (High vs Moderate vs Poor)0.760.56-1.020.069
E-cadherin expression (Positive vs Negative)1.180.84-1.660.337
Invasion (Mucosa vs Muscularis vs Full)0.650.45-0.920.015a0.490.331-0.711< 0.001a
EMT (Epithelial vs Mixed vs Mesenchymal)1.361.06-1.740.016a1.220.867-1.7190.253
SOX2 expression (Positive vs Negative)1.441.03- 2.030.034a1.531.06-2.200.022a
Vimentin expression (Positive vs Negative)1.511.06- 2.130.022a1.370.83-2.260.224